Host a Marketing Presentation

Product Theaters are turnkey, 45-minute marketing presentations about your company’s products or services. These sessions do not offer CME credit; rather, they give industry supporters the freedom to create a presentation centered on their company’s products. Additional information will be available soon.

Product Theater

Eligibility

Only DDW industry supporters who have secured exhibit space or participating in the virtual event are eligible to apply for a Product Theater (PT) slot, subject to availability and adherence to all published guidelines. In the event a company reserves an exhibit space but cancels prior to DDW or is a no-show on the exhibit floor, permission to hold the product theater will be revoked. This policy will be strictly enforced, no refunds will be given, and any violation will result in the loss of priority points earned for DDW 2022 for the supporting company. Product Theaters for 2022 are currently sold out.

Rules and Regulations

Product theaters are limited and will be assigned by DDW on a first-come, first-served basis. View the available times.

The fee for one time slot is $25,000. Companies are eligible to secure more than one time slot.

All DDW Product Theaters and Marketing Opportunities will be billed at 100% upon selection and execution of the application and sponsorship contracts. Payment is due no later than 30 days from the date of order. Failure to make full payment by this date will result in the item being placed back into inventory for another party to purchase and Product Theater organizers will incur cancellation fees for the Product Theater fee (see below). All payments are non-refundable after Jan. 21, 2022. DDW reserves the right to reject or resell any opportunity if payment is not received within 30 days. If an order is placed after Jan. 31, 2022, payment will be due upon reservation. DDW reserves the right to not fulfil any unpaid Marketing Opportunities. Space will be assigned only after full payment has been received based on availability at that time.

Notification of product theaters must be in writing. Any supporter canceling a product theater will be charged a fee based on the following schedule:

  • On or before Feb. 14, 2022: 50% of total fee is due, regardless of whether the slot is re-sold.
  • After Feb. 14, 2022: 100% of total fee is due, regardless of whether the slot is re-sold. Product Theater cancellations will result in automatic cancellation of any marketing opportunities secured for the Product Theater. No refunds will be provided for these other opportunities.

The sponsoring company shall be solely responsible for the management of the logistics of their PT, and for payment of additional costs related to the PT including but not limited to catering, electrical, internet, etc. DDW does not provide logistical support for product theaters apart from those services specifically listed below.

Freeman AV is the exclusive provider of audio-visual services. Expenses for additional services and additional electrical costs incurred are the responsibility of the sponsoring company. Any additional equipment needed must be approved by DDW and items must not alter the setup of the product theater in any way. Added items will need to be added for the entire day as not to impactor disturb other product theaters or activities scheduled in this space.

The following AV is included:

  • Two lavaliere microphones.
  • One podium microphone.
  • One wired aisle microphone.
  • Two 70 monitors
  • Sound amplification and mixer system.
  • VGA switcher.
  • Electricity for the above.

Lead retrieval will not be provided. If you wish to collect leads from your product theater, it is your responsibility to coordinate.

The product theater area must be cleared within 45 minutes of the end of each presentation.

If you wish to have a hybrid or virtual component for your Product Theater, it is your responsibility to coordinate. DDW will place a listing within the virtual platform and on DDW.org. Supporters will be responsible for providing the link to the hybrid or virtual Product Theater or recording. Link to your meeting room, website or recording will be due to DDW by April 15, 2022. If you record your on-site or virtual Product Theater, DDW will host your recording on DDW.org through Aug. 31, 2022. More information will be provided once a contract is submitted.

  • Assign day and time.
  • Upon request, provide a complimentary mailing list of pre-registered attendees.
  • List the Product Theater in the DDW mobile app, DDW.org, DDW virtual platform and DDW Online Planner (if PT is reserved by March 17, 2022).
  • Theater in DDW Exhibit Hall that will seat up to 100 people.
  • Day of push notifications on the mobile app.
  • Industry Supporter Showcase poster.

Pre-Meeting Policies

  • All products and services discussed at DDW shall be related to digestive health or GI practice and to DDW’s mission and must be of professional or educational benefit or interest to meeting participants.
  • Programs may NOT offer CME credit.
  • Promotional and marketing materials: All promotional and marketing materials must be approved by DDW prior to distribution. It is the sole responsibility of the sponsor to work with DDW to receive approval of materials.
  • 50 words or less of promotional copy, for use in the DDW Online Planner, DDW Mobile App and other official DDW materials, is due March 17, 2022. Failure to provide content by this date will result in DDW only listing the topic and sponsoring organization on all published materials. DDW will not alter any signage or other published materials after this date.

On-Site Policies: Posters and Flyers

Posters or flyers may be displayed and distributed in the following locations only:

  • The exhibiting company’s booth
  • Outside the Product Theater (posters only and must be within five feet of the theater)
  • Industry Showcase Area
  • Symposia Central Area

  • All material must contain the following statement: "The Product Theater content and views expressed therein are those of the sponsor and not of Digestive Disease Week®."
  • The DDW logo may not be used in any promotions, advertisements, meeting materials or correspondence related to the program.

  • Application deadline: March 17, 2022
  • Payment: Jan. 31, 2022
  • Faculty list: March 17, 2022
  • Title: March 17, 2022
  • 50 word description: March 17, 2022
  • Educational tracks (Choose up to 3): March 17, 2022
  • Link to virtual component or recording: April 15, 2022

Supporters are encouraged to provide catering at their own expense for the participants attending the Product Theater. If the supporter is providing food and beverage for your Product Theater, it is your responsibility to order porter service to clean the area for the next group. It is the supporter's responsibility to ensure the area is cleared quickly at the end of your session. Supporters will ensure that attendees and speakers have cleared the area immediately after the event.

The supporting company and affiliates shall indemnify DDW and its components societies against all claims, demands, actions, expenses, damages, penalties, attorney’s fees, or proceedings incurred by DDW because of the publications distributed at, statements made during or any other conduct arising out of or in any way connected with the Product Theater.

The Product Theater area will not be secured. DDW will not be liable for damage or loss to the supporting company's property, nor shall DDW be liable for any injury that may occur in the area.

Failure to comply with any of these rules will result in the loss of priority points earned for DDW 2022 for the exhibiting company.

Calendar

  • May 21
  • May 22
  • May 23

Friday, May 21, 2021

DDW Theater 1 (Hall F)Takeda
Moving Treatment Forward in Chronic Idiopathic Constipation (CIC): A New Option
9:30–10:15 a.m.
This program will discuss the efficacy and safety of a new treatment option for adults with CIC, as well as the unmet need, trial design, mechanism of action and dosing/administration.
EndoGastric Solutions
Shaping the Future of GERD: Now is the Time for TIF 2.0 Procedure
11:30 a.m.–12:15 p.m.
The TIF 2.0 procedure using the EsophyX Z+ device is shaping the future of GRED treatment. Innovators will discuss the latest clinical results and how TIF 2.0 can be used in a broader spectrum of patient populations.
Intercept Pharmaceuticals, Inc
Topics in Advanced Fibrosis due to Nonalcoholic Steatohepatitis (NASH)
1:30–2:15 p.m.
Presented by Dr. Mazen Noureddin, MD MHSc., Director Fatty Liver Program, Division of Digestive and Liver Diseases, Comprehensive Transplant Center, Cedars-Sinai® Medical Center, California.
DDW Theater 2 (Hall B1)Allergan/Ironwood
A Proactive Management Approach to IBS‐C and CIC
10:30–11:15 a.m.
IBS-C and CIC, prevalent disorders with chronic and burdensome symptoms, impacts ~40 million Americans and is associated with a high healthcare system cost. Currently, only 16 million seek care, which leaves many untreated and still suffering. Come to a clinical review of a proactive treatment that may help your patients.
Salix Pharmaceuticals
A Closer Look at Diagnosis, Microbial Imbalance and a Short-Term Treatment Option
12:30–1:15 p.m.
Dr. Ali Rezaie, medical director of the GI motility program at Cedars Sinai Medical Center, Los Angeles, will provide a closer look at IBS-D Diagnosis, Microbial Imbalance and discuss a Short-Term Treatment Option.
Mayo Clinic Laboratories
Early-Onset IBD: Genetic Testing and Its Clinical Application
2:30–3:15 p.m.
Identification of early-onset IBD patients may enable tailored treatment and surveillance plans. With over 50 genes implicated in early-onset IBD, genetic testing should be included in the workup of children under the age of six with IBD. Join Mayo Clinic for a discussion of this testing and its clinical application.

Saturday, May 22, 2021

DDW Theater 1 (Hall F)STERIS | US Endoscopy
Tips, Techniques and Tools for Advanced Polypectomy
9:30–10:15 a.m.
David L. Diehl, MD, FASGE, director of interventional endoscopy, Geisinger Medical Center, Danville, PA, will lead a discussion around tips, techniques and the latest tools for managing flat polyps, defect closure and electrosurgery applications.
Allergan
A Proactive Way to Treat IBS-D: Post-Marketing Information and Phase 4 Data
11:30 a.m.–12:15 p.m.
Please join us in a clinical review of exciting Phase 4 data and the latest post-marketing information on a proactive treatment that may help your IBS-D patients. IBS-D is a chronic functional disorder of the GI system that affects approximately 16 million people and 40% suffers remain undiagnosed.
STERIS | US Endoscopy
Avulsion: A novel technique to achieve complete resection of difficult colon polyps
1:30–2:15 p.m.
Gregory Haber, MD, chief of endoscopy and director of advanced therapeutics and innovation, NYU Langone Medical Center, New York, NY, will lead a discussion around the avulsion technique — using hot biopsy forceps to grasp tissue, apply a mechanical force, while applying bursts of a cutting current with minimal cautery.
DDW Theater 2 (Hall B1)Takeda Pharmaceuticals International
Learn about a treatment option for your patients with moderate to severe Crohn’s Disease (CD) who may be ready to begin a biologic therapy
10:30–11:15 a.m.
In this program, expert gastroenterologist Dr. Brian Feagan will discuss the mechanism of action and clinical profile of a therapeutic option for adult patients with moderate to severe CD who may be ready for a biologic.
Salix Pharmaceuticals
PLENVU: A Novel Bowel Preparation for Patients to Achieve Successful Cleaning
12:30–1:15 p.m.
Dr. Brooks Cash, chief, Division of Gastroenterology, Hepatology & Nutrition, University of Texas Health Science Center at Houston, will be discussing a novel bowel preparation for patients to achieve successful cleaning.
AbbVie
Targeting Disease Activity in UC on the Journey to Remission
2:30–3:15 p.m.
Join us on a journey to find clinical remission featuring real patients with ulcerative colitis from a clinical trial and highlighting the importance of proper induction and optimizing the patient experience.

Sunday, May 23, 2021

DDW Theater 1Janssen Biotech, Inc.
Janssen Biotech, Inc. Product Theater Presentation
9:30–10:15 a.m.
Speaker: Anita Afali, MD, MPH, FACG
CDx Diagnostics
CDx Diagnostics Product Theater Presentation
11:30 a.m.–12:15 p.m.
Description will be coming soon.

Related Opportunities

Satellite Symposia

Industry Supporters can host educational programs before or after DDW scientific sessions.
ICWs are meetings and events arranged by exhibitors, third party planners, educational institutions or other non-profit organizations during DDW.

In-Conjunction With Meetings

ICWs are meetings and events arranged by exhibitors, third-party planners, educational institutions or other non-profit organizations during DDW.
Two women at computer in Exhibit Hall

Industry Supporter Prospectus

The prospectus provides details you need to know to reserve your space at DDW 2022.